Retinoblastoma is a malignant tumour that develops in the retina, the light-sensitive layer of tissue at the back of the eye. It most commonly occurs in young children, typically before the age of five, and can affect one or both eyes. If left untreated, retinoblastoma can spread to other parts of the body and become life-threatening. However, with early diagnosis and appropriate treatment, the prognosis is highly favourable.
This disease is not only emotionally challenging for families but also requires a multidisciplinary approach for successful management. Understanding its early signs, diagnostic procedures, and treatment methods can significantly impact outcomes.
Retinoblastoma is a rare form of eye cancer that originates in the retina. It occurs when nerve cells in the retina mutate and grow uncontrollably, forming a tumour. The condition can be hereditary or non-hereditary and may present in one (unilateral) or both (bilateral) eyes.
The retina is critical for vision, converting light into nerve signals that are interpreted by the brain. Any disruption in this delicate system can impair sight. Retinoblastoma, if not caught early, may lead to blindness or metastasis (spread to other organs).
In India, retinoblastoma accounts for about 3% of all childhood cancers. According to studies, the incidence is approximately 4 to 5 cases per million children under the age of five. Late diagnosis is more common in low-income regions due to lack of awareness and access to healthcare.
Globally, retinoblastoma affects around 8,000 children each year. The disease is more prevalent in developing countries where delayed diagnosis and limited treatment facilities contribute to higher mortality rates. In high-income countries, survival rates exceed 90% thanks to early detection and advanced medical care.
Heritable forms are more likely to result in multiple tumours and require closer monitoring for secondary cancers.
Retinoblastoma develops due to mutations in the RB1 gene located on chromosome 13. This gene helps regulate cell growth. When mutated, it fails to stop cells from dividing uncontrollably.
Causes may include:
Unlike many adult cancers, environmental and lifestyle factors are not known to play a significant role in retinoblastoma.
These symptoms may not always indicate cancer but require immediate medical evaluation, especially in young children.
Early and accurate diagnosis is crucial to preserving vision and life.
Treatment plans are individualised based on tumour size, location, and whether one or both eyes are affected.
While alternative therapies like Ayurveda and homeopathy are sometimes considered by families, they are not substitutes for evidence-based medical care. Supportive therapies like:
may be used alongside conventional treatments to improve emotional and psychological well-being.
Genetic counselling is often recommended for families with a history of the disease.
Early intervention greatly reduces the risk of severe complications
Parental involvement and encouragement play a key role in a child’s adaptation.
Misinformation can delay treatment, so awareness is vital.
Early medical attention can save a child’s sight and life.
Community and familial support can make a world of difference.
Retinoblastoma is a rare but serious eye cancer that primarily affects children under five. With early diagnosis and comprehensive treatment, most children can survive and lead healthy lives. Raising awareness, promoting genetic counselling, and ensuring access to healthcare are essential steps in combating this disease. Empowering families with knowledge and support improves not only survival rates but also the overall quality of life.